London
· Delayed Price · Currency is GBP · Price in GBXBioventix Statistics
Total Valuation
Bioventix has a market cap or net worth of GBP 173.55 million. The enterprise value is 167.55 million.
| Market Cap | 173.55M |
| Enterprise Value | 167.55M |
Important Dates
The next estimated earnings date is Tuesday, December 24, 2024.
| Earnings Date | Dec 24, 2024 |
| Ex-Dividend Date | Nov 7, 2024 |
Share Statistics
Bioventix has 5.22 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 5.22M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 6.01% |
| Owned by Institutions (%) | 62.01% |
| Float | 4.17M |
Valuation Ratios
The trailing PE ratio is 21.75 and the forward PE ratio is 19.44.
| PE Ratio | 21.75 |
| Forward PE | 19.44 |
| PS Ratio | 12.76 |
| PB Ratio | 14.46 |
| P/TBV Ratio | 14.46 |
| P/FCF Ratio | 20.84 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.60, with an EV/FCF ratio of 20.12.
| EV / Earnings | 20.69 |
| EV / Sales | 12.31 |
| EV / EBITDA | 15.60 |
| EV / EBIT | 15.77 |
| EV / FCF | 20.12 |
Financial Position
The company has a current ratio of 7.42
| Current Ratio | 7.42 |
| Quick Ratio | 4.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 67.29% and return on invested capital (ROIC) is 55.19%.
| Return on Equity (ROE) | 67.29% |
| Return on Assets (ROA) | 49.17% |
| Return on Capital (ROIC) | 55.19% |
| Revenue Per Employee | 800,387 |
| Profits Per Employee | 476,278 |
| Employee Count | 17 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 1.57 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.18% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.18% |
| 50-Day Moving Average | 3,655.20 |
| 200-Day Moving Average | 4,137.58 |
| Relative Strength Index (RSI) | 25.66 |
| Average Volume (20 Days) | 4,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioventix had revenue of GBP 13.61 million and earned 8.10 million in profits. Earnings per share was 1.53.
| Revenue | 13.61M |
| Gross Profit | 12.68M |
| Operating Income | 10.63M |
| Pretax Income | 10.60M |
| Net Income | 8.10M |
| EBITDA | 10.74M |
| EBIT | 10.63M |
| Earnings Per Share (EPS) | 1.53 |
Balance Sheet
| Cash & Cash Equivalents | 6.00M |
| Total Debt | n/a |
| Net Cash | 6.00M |
| Net Cash Per Share | 1.15 |
| Equity (Book Value) | 12.00M |
| Book Value Per Share | 2.30 |
| Working Capital | 11.10M |
Cash Flow
In the last 12 months, operating cash flow was 8.34 million and capital expenditures -15,907, giving a free cash flow of 8.33 million.
| Operating Cash Flow | 8.34M |
| Capital Expenditures | -15,907 |
| Free Cash Flow | 8.33M |
| FCF Per Share | 1.60 |
Margins
Gross margin is 93.20%, with operating and profit margins of 78.10% and 59.51%.
| Gross Margin | 93.20% |
| Operating Margin | 78.10% |
| Pretax Margin | 77.92% |
| Profit Margin | 59.51% |
| EBITDA Margin | 78.93% |
| EBIT Margin | 78.10% |
| FCF Margin | 61.21% |
Dividends & Yields
This stock pays an annual dividend of 1.55, which amounts to a dividend yield of 4.66%.
| Dividend Per Share | 1.55 |
| Dividend Yield | 4.66% |
| Dividend Growth (YoY) | 1.97% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 101.86% |
| Buyback Yield | -0.14% |
| Shareholder Yield | 4.52% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioventix has an Altman Z-Score of 80.96.
| Altman Z-Score | 80.96 |
| Piotroski F-Score | n/a |